- Curis (CRIS) +199% on encouraging CA-4948 data in leukemia.
- NeuroMetrix (NURO) +84%.
- Stitch Fix (SFIX) +39% on Q1 results.
- Lexicon Pharmaceuticals (LXRX) +31%.
- Cancer Genetics (CGIX) +28%.
- Smartsheet (SMAR) +18% on Q3 results.
- Tarena (TEDU) +18% on founder's going private proposal at $4/ADS.
- Platinum Group Metals (PLG) +17%.
- Hollysys Automation Technologies (HOLI) +17% on takeout proposal at $15.47/share.
- QuantumScape (QS) +15% on performance data for its solid-state battery technology.
- CLPS (CLPS) +14% on deal with a client in automotive industry for big data-enabled vehicle intelligent manufacturing system.
- Foley Trasimene Acquisition II (BFT) +13%.
- Liquidity Services (LQDT) +12% on FQ4 results.
- electroCore (ECOR) +5% on positive top-line results from premium II migraine prevention study.
- Uranium Energy (UEC) +10%.
- Mereo BioPharma (MREO) +10%.
- Futu Holdings (FUTU) +10% on selling securities for an aggregate $260M.
- Velodyne Lidar (VLDR) +9% as Velodyne’s Velarray H800 and PAEB Solution to power advanced driver assistance systems and autonomy.
- Luminar Technologies (LAZR) +9%.
- InterPrivate Acquisition (IPV) +9%.
- HL Acquisitions (HCCH) +8%.
- Antero Resources (AR) +7%.
- Ampio Pharmaceuticals (AMPE) +7%.
- MP Materials (MP) +7%.
- Nano Dimension (NNDM) +7%.